Company News

Priority Technology (PRTH) reports Q4 Adjusted EPS of $0.11, Revenue Up 8.8%

Priority Technology (PRTH) reports Q4 Adjusted EPS of $0.11, Revenue Up 8.8%

Priority Technology Holdings posted Q4 adjusted EPS of $0.27, up 621% year-over-year, with revenue climbing 8.8% to $247.1 million.

Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate; Shares Surge 19%

Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate; shares jump 19% as clinical-stage biotech shows sequential improvement.

Septerna (SEPN) Reports Narrower Q4 Loss of $0.24/Share as Revenue Climbs to $24.1M

Septerna reports Q4 loss of $0.24/share, wider than expected, as revenue climbs to $24.1M from minimal levels earlier in fiscal…

BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Guides 2026 Revenue to $130M-$135M

BETA Technologies reported a Q4 loss of $1.71/share vs expected $0.47 loss, but guided 2026 revenue to $130M-$135M as certification…

FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate, Revenue Misses by 29.5%

FuelCell Energy narrows Q1 loss to $0.52/share vs $0.68 estimate, but revenue of $30.5M misses $43.3M consensus by 29.5% on…

Yalla Group (YALA) Reports Q4 EPS of $0.20 as Revenue Stalls at $83.9M

Yalla Group reports Q4 adjusted EPS of $0.21 on flat sequential revenue of $83.9M, maintaining profitability but showing zero growth.

Yalla Group (YALA) Q4 Earnings Flat at $0.21 EPS, $83.9M Revenue Signals Growth Stall

Yalla Group's Q4 adjusted EPS of $0.21 and revenue of $83.9M matched the prior quarter exactly, signaling a growth plateau.

FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate; Revenue Misses by 30%

FuelCell Energy narrows Q1 loss to $0.52/share vs $0.68 estimate, but revenue of $30.5M misses $43.3M consensus by 30% on…

Yext (YEXT) Q4 Earnings: $0.15 EPS as Revenue Flatlines at $112M

Yext reports Q4 adjusted EPS of $0.15, matching prior quarter, as revenue stalls at $112M year-over-year.

Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share

Boundless Bio narrows Q4 loss to $0.58/share and posts first-ever revenue of $17.3M, guiding to $78-80M for 2026.